Efficacy of autologous microfat graft on facial handicap in systemic sclerosis patients

Plastic and Reconstructive Surgery - Global Open

Volumn 4, Issue 3, 2016, Pages

  Sautereau, Nolwenn ^a   Daumas, Aurélie ^a   Truillet, Romain ^a   Jouve, Elisabeth ^a   Magalon, Jéremy ^a   Veran, Julie ^a   Casanova, Dominique ^a   Frances, Yves ^a   Magalon, Guy ^a   Granel, Brigitte ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85029735309     PISSN: None     EISSN: 21697574     Source Type: Journal    
DOI: 10.1097/GOX.0000000000000621     Document Type: Article

References (33)

1. Wood RE, Lee P. Analysis of the oral manifestations of systemic sclerosis (scleroderma). Oral Surg Oral Med Oral Pathol. 1988; 65:172-178.
2. Vincent C, Agard C, Barbarot S, et al. [Orofacial manifestations of systemic sclerosis: a study of 30 consecutive patients]. Rev Med Interne. 2009; 30:5-11.
3. Avouac J, Sordet C, Depinay C, et al. Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum. 2006; 54:2243-2249.
4. Scardina GA, Pizzigatti ME, Messina P. Periodontal micro-circulatory abnormalities in patients with systemic sclerosis. J Periodontol. 2005; 76:1991-1995.
5. Coleman SR Structural fat grafting: more than a permanent filler. Plast Reconstr Surg. 2006; 118(3 Suppl):108S-120S.
6. Meruane MA, Rojas M, Marcelain K. The use of adipose tissue-derived stem cells within a dermal substitute improves skin regeneration by increasing neoangiogenesis and collagen synthesis. Plast Reconstr Surg. 2012; 130:53-63.
7. Sultan SM, Stern CS, Allen RJ Jr, et al. Human fat grafting alleviates radiation skin damage in a murine model. Plast Reconstr Surg. 2011; 128:363-372.
8. Klinger M, Caviggioli F, Vinci V, et al. Treatment of chronic posttraumatic ulcers using autologous fat graft. Plast Reconstr Surg. 2010; 126:154e-155e.
9. Oh CK, Lee J, Jang BS, et al. Treatment of atrophies secondary to trilinear scleroderma en coup de sabre by autologous tissue cocktail injection. Dermatol Surg. 2003; 29:1073-1075.
10. Palmero ML, Uziel Y, Laxer RM, et al. En coup de sabre scleroderma and Parry-Romberg syndrome in adolescents: surgical options and patient-related outcomes. J Rheumatol. 2010; 37:2174-2179.
11. Consorti G, Tieghi R, Clauser LC. Frontal linear sclero-derma: long-term result in volumetric restoration of the fronto-orbital area by structural fat grafting. J Craniofac Surg. 2012; 23:e263-e265.
12. Nguyen PS, Desouches C, Gay AM, et al. Development of micro-injection as an innovative autologous fat graft technique: the use of adipose tissue as dermal filler. J Plast Reconstr Aesthet Surg. 2012; 65:1692-1699.
13. Djaffar O-A. Bleomycin-induced scleroderma in nude mice can be reversed by injection of adipose tissue: evidence for a novel therapeutic intervention in systemic sclerosis. J Clin Exp Dermatol Res. 2012; 3:164-168.
14. Alharbi Z, Opländer C, Almakadi S, et al. Conventional vs. micro-fat harvesting: how fat harvesting technique affects tissue-engineering approaches using adipose tissue-derived stem/stromal cells. J Plast Reconstr Aesthet Surg. 2013; 66:1271-1278.
15. Mouthon L, Rannou F, Bérezné A, et al. Development and validation of a scale for mouth handicap in systemic sclerosis: the Mouth Handicap in Systemic Sclerosis scale. Ann Rheum Dis. 2007; 66:1651-1655.
16. van den Hoogen F, Khanna D, Fransen J, et al. 2013 Classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013; 72:1747-1755.
17. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988; 15:202-205.
18. Clements PJ, Lachenbruch PA, Seibold JR, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol. 1993; 20:1892-1896.
19. Placko G, Bellot-Samson V, Brunet S, et al. [Normal mouth opening in the adult French population]. Rev Stomatol Chir Maxillofac. 2005; 106:267-271.
20. Dobrev HP In vivo study of skin mechanical properties in patients with systemic sclerosis. J Am Acad Dermatol. 1999; 40:436-442.
21. Thomson WM, Chalmers JM, Spencer AJ, et al. The Xerostomia Inventory: a multi-item approach to measuring dry mouth. Community Dent Health. 1999; 16:12-17.
22. Thomson WM Measuring change in dry-mouth symptoms over time using the Xerostomia Inventory. Gerodontology 2007; 24:30-35.
23. Poole JL, Steen VD. The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res. 1991; 4:27-31.
24. Maddali-Bongi S, Landi G, Galluccio F, et al. The rehabilitation of facial involvement in systemic sclerosis: efficacy of the combination of connective tissue massage, Kabat's technique and kinesitherapy: a randomized controlled trial. Rheumatol Int. 2011; 31:895-901.
25. Del Papa N, Caviggioli F, Sambataro D, et al. Autologous fat grafting in the treatment of fibrotic perioral changes in patients with systemic sclerosis. Cell Transplant 2015; 24:63-72.
26. Zuk PA Adipose-derived stem cells in tissue regeneration: a review. ISRN Stem Cells 2013:35.
27. Ong WK, Sugii S. Adipose-derived stem cells: fatty potentials for therapy. Int J Biochem Cell Biol. 2013; 45:1083-1086.
28. Leto Barone AA, Khalifian S, Lee WP, et al. Immunomodulatory effects of adipose-derived stem cells: fact or fiction? Biomed Res Int. 2013; 2013:383685.
29. Ichim TE, Alexandrescu DT, Solano F, et al. Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cell Immunol. 2010; 260:75-82.
30. Cao Y. Tumor angiogenesis and therapy. Biomed Pharmacother. 2005; 59(suppl 2):S340-S343.
31. Nakagami H, Morishita R, Maeda K, et al. Adipose tissuederived stromal cells as a novel option for regenerative cell therapy. J Atheroscler Thromb. 2006; 13:77-81.
32. Miyahara Y, Nagaya N, Kataoka M, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med. 2006; 12:459-465.
33. Scuderi N, Anniboletti T, Carlesimo B, et al. Clinical application of autologous three-cellular cultured skin substitutes based on esterified hyaluronic acid scaffold: our experience. In Vivo. 2009; 23:991-1003.